As more plans accept obesity as a medical condition, insurance coverage for Zepbound grows
Results from a post hoc subgroup analysis of the SURMOUNT-1 study (NCT04184622), published this year [87] , demonstrated that among 32 pathogenic MC4R variant carriers (1.4% of the study population) with a median age of 41.06 years and a BMI 40 kg/m 2 , treatment with tirzepatide for 72 weeks resulted in an 18.3% reduction in body weight from baseline
William Blair may or may not own any securities of the issuers referenced and, if such securities are owned, no representation is being made that such securities will continue to be held
The medicines can cause unwanted gastrointestinal side effects, such as nausea, vomiting, and diarrhea, which might make someone less interested in drinking
Check the manufacturers savings card websites to see if you qualify for any savings card programs
Similar findings were seen with once-weekly, subcutaneous tirzepatide (5 mg, 10 mg, or 15 mg) [27], demonstrating the utility of GLP-1RAs for obesity management
